Results

Total Results: 108 records

Showing results for "discharge".
Users also searched for: discharge planning

81. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-cancer-medications-for-risk-reduction-2002
    May 06, 2002 - placebo group, statistical significance not given) and "quite a bit" or "extremely" bothersome vaginal discharge

82. Primary Care Interventions to Prevent Child Maltreatment: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/DPq7_eawq-Ts6XLowaTaNA
    November 27, 2018 - A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants

83. Evidence Summary: High Body Mass Index in Children and Adolescents: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/obesity-in-children-and-adolescents-screening
    June 18, 2024 - = 579 Gastrointestinal adverse effects were more common with orlistat use, including flatus with discharge

84. 3W8Wr9Wwayaqujwmjo Bl- (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/3w8Wr9wwAyAqUJWmJo_bL-
    February 01, 2014 - The most common adverse effects were vasomotor symp- toms and vaginal discharge, itching, or dryness

85. Archived: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2013
    September 15, 2013 - The most commonly reported adverse effects in these trials were vasomotor symptoms and vaginal discharge

86. Recommendation: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing
    August 20, 2019 - placebo or raloxifene. 79 , 90 The most common adverse effects were vasomotor symptoms and vaginal discharge

87. Interventions for Weight Management in Children and Adolescents: Updated Evidence Report and Systematic Review for the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/e9f8a_uGMXxSbBUxpRPkrc
    June 18, 2024 - n = 579 Gastrointestinal adverse effects were more common with orlistat use, including flatus with discharge

88. Zvvry6Wa4Sgj-Ejb3Brcvy (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/zVVRY6wa4Sgj-EJb3BRcVy
    November 01, 2013 - The most commonly reported adverse effects in these trials were vasomotor symptoms and vaginal discharge

89. JAMA (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/pACFPdCoN8fVoddBs-_CLE
    November 12, 2019 - with placebo or raloxifene.79,90 The most common adverse effects were vasomotor symptoms and vaginal discharge

90. Archived: Evidence Summary: Falls Prevention in Community-Dwelling Older Adults: Interventions | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/falls-prevention-in-older-adults-interventions-2018
    April 17, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Falls Prevention in Community-Dwelling Older Adults: Interventions April 17, 2018 Recommendations made by the USPSTF are independent of the U.S.…

91. Final Evidence Summary: Hepatitis C Virus Infection in Adolescents and Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hepatitis-c-screening
    March 02, 2020 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Evidence Summary Hepatitis C Virus Infection in Adolescents and Adults: Screening March 02, 2020 Recommendations made by the USPSTF are independent of the U.S. govern…

92. Archived: Evidence Summary: BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary17/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing-2013
    December 15, 2013 - The most common adverse effects were vasomotor symptoms and vaginal discharge, itching, or dryness for

93. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
    April 15, 2013 - The most common side effects were vasomotor symptoms 11 , 24 , 28 , 31  and vaginal discharge, itching

94. Use of Medications to Reduce Risk for Primary Breast Cancer: A Systematic Review of the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/7ZSKduUYHWKe7q_tTY9xbF
    April 01, 2013 - The most common side effects were vasomotor symp- toms (11, 24, 28, 31) and vaginal discharge, itching

95. Folic Acid Supplementation for the Prevention of Neural Tube Defects: An Updated Evidence Report and Systematic Review (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/MWRHULpw6y_5Uk_KXTyvp8
    January 10, 2017 - It identified cases, largely from hospital discharge records; randomly selected controls; and identified

96. Archived: Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
    June 20, 2017 - Flatus with discharge was reported by 20% to 43% of those taking orlistat and 3% to 11% of those receiving

97. Z8Avschjezubsjtdsx424H (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/z8AVsCHJEZUBSJtdSx424H
    May 23, 2019 - brief motivational interviewing, skills-based counseling, or usual care on alcohol consumption after discharge

98. Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review of the USPSTF (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/nMb54adBfgajp8dG87kPcw
    April 17, 2018 - Interventions to Prevent Falls in Older Adults: Updated Evidence Report and Systematic Review of the USPSTF Interventions to Prevent Falls in Older Adults Updated Evidence Report and Systematic Review for the US Preventive Services Task Force Janelle M. Guirguis-Blake, MD; Yvonne L. Michael, ScD, SM; Leslie A. Perdue…

99. Archived: Final Evidence Summary: Obesity in Children and Adolescents: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary39/obesity-in-children-and-adolescents-screening-2010
    January 15, 2010 - and 20% to 30% reported oily spotting, oily evacuation, abdominal pain, fecal urgency, or flatus with discharge

100. Archived: Evidence Summary: Breast and Ovarian Cancer: BRCA Genetic Testing, September 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/breast-and-ovarian-cancer-brca-testing-screening-2005
     September 15, 2005 - ). 133 Trials reported significantly increased cataracts; 134 hot flashes; 133-135 , 144 vaginal discharge